Ipsen UK & Ireland are a core part of Ipsen’s global biopharmaceutical business and are driven by the belief that patients don’t have time to wait. We have a biotech mindset coupled with pharmaceutical capabilities and have invested in a robust business presence that spans the early stages of R&D (Abingdon, Oxford) through to in-house manufacturing (Wrexham, Wales & Dublin, Ireland) so we can effectively deliver on our promise to UK & Irish patients.

As part of this investment, we employ over 900 people across our four sites, including our commercial headquarters in Bath Road, Slough. Our business focuses on oncology, neurosciences and rare diseases, to create innovative therapies in areas of high unmet medical need. Ipsen works across a diverse oncology portfolio, which includes prostate cancer, neuroendocrine tumours and renal cell carcinoma. Our licensed medicines and R&D are all are focused on curing disease and relieving suffering, hoping to bring real value to the healthcare community along every step of the treatment pathway.